A public company has historically excluded restructuring charges from adjusted EBITDA. In its current-year earnings release, management labels a litigation settlement gain as 'non-recurring' and excludes it from adjusted EBITDA, even though similar litigation settlement gains occurred in each of the prior three years and are reasonably likely to recur. Which presentation would best support a comparable and nonmisleading analysis?
- AInclude the litigation settlement gain in adjusted EBITDA given its demonstrated recurrence, and reconcile the measure to the most comparable GAAP measure.
- BExclude the litigation settlement gain and describe it as non-recurring only in a footnote disclosure.
- CExclude the litigation settlement gain from adjusted EBITDA without providing a reconciliation because it relates to a legal matter.
- DContinue labeling the gain as non-recurring in the earnings release because management does not expect the same litigation to occur again.
Show answer and rationale
Answer: A. Include the litigation settlement gain in adjusted EBITDA given its demonstrated recurrence, and reconcile the measure to the most comparable GAAP measure.
Rationale
Include the litigation settlement gain in adjusted EBITDA given its demonstrated recurrence, and reconcile the measure to the most comparable GAAP measure.
- Similar settlement gains occurred in each of the prior three years and are reasonably likely to recur, so calling this gain “non-recurring” would mislead users.
- Including the gain and reconciling adjusted EBITDA to the most comparable GAAP measure supports a transparent comparison, regardless of the company’s historical exclusion of restructuring charges.
Exclude the litigation settlement gain and describe it as non-recurring only in a footnote disclosure.
- Moving the “non-recurring” label to a footnote does not make it accurate when similar gains have recurred for three years.
- The footnote would not cure the misleading effect of excluding a reasonably likely recurring gain on that basis.
Exclude the litigation settlement gain from adjusted EBITDA without providing a reconciliation because it relates to a legal matter.
- A gain’s connection to litigation does not excuse a public company from reconciling adjusted EBITDA to the most comparable GAAP measure.
- Excluding the gain without a reconciliation would also obscure how a historically recurring type of item affects the measure.
Continue labeling the gain as non-recurring in the earnings release because management does not expect the same litigation to occur again.
- The question is whether similar settlement gains recur, not whether the identical lawsuit will recur.
- Gains occurred in each of the prior three years and are reasonably likely to recur, making the “non-recurring” label misleading.